Jason Glenn, M.D.

I am a board-certified general surgeon. My goal is to provide world-class care close to home. I would describe myself as a thoughtful, compassionate and skilled surgeon who strives to develop trust and rapport with all of my patients. It is critical for patients to understand their condition and the proposed treatment so that they can be an active participant in the decision-making process.

I was born, raised and did most of my schooling and training in the Midwest. I completed my fellowship at one of the premier training programs in the country. I have practiced in high-acuity tertiary care centers as well as rural critical access hospitals.

I enjoy spending time with my kids, watching college sports, fishing, gardening and exploring the outdoors whenever possible. I also have a passion for surgical mission trips and surgical education.

Education

• Howard University College of Medicine

Residency

• General Surgery, Medical College of Wisconsin

Fellowship

• Endocrine Surgery, University of Michigan

Certification

• General Surgery, American Board of Surgery

Memberships

• American Association of Endocrine Surgeons
• American College of Surgeons
• Minnesota Surgical Society

Academic Appointment

• Assistant Professor of General Surgery, Mayo Clinic College of Medicine and Science

• Abdominal wall hernias
• Endocrine surgery, including thyroid, parathyroid and adrenal surgery
• Graves' disease
• Thyroid cancer
• Thyroid nodule radiofrequency ablation

• Longitudinal patterns of recurrence in patients with adrenocortical carcinoma, January 2019.
• Role of additional organ resection in adrenocortical carcinoma: Analysis of 167 patients from the U.S. Adrenocortical Carcinoma Database, August 2018.
• A novel T-stage classification system for adrenocortical carcinoma: Proposal from the U.S. Adrenocortical Carcinoma Study Group, February 2018.
• Blood transfusion and survival for resected adrenocortical carcinoma: A study from the United States Adrenocortical Carcinoma Group, July 2017.
• Curative surgical resection of adrenocortical carcinoma: Determining long-term outcome based on conditional disease-free probability, January 2017.